Search in the Abstract Database

Search Abstracts 2011

* = Presenting author

P283. Treatment quality of patients suffering from IBD could be improved and costs significantly lowered by establishing a network between gastroenterologists and a health insurance in the Rhein-Main Region, Germany

I. Blumenstein1, W. Tacke2, H. Bock2, V. Heuzeroth3, J. Hausmann1, S. Zeuzem1, O. Schröder1

1University Clinic Frankfurt, Frankfurt, Germany; 2Quality Management Group of Gastroenterologists in Hesse, Frankfurt, Germany; 3BKK Taunus (Gesundheit), Frankfurt, Germany

Introduction: In our previous studies investigating the medication therapy given to patients suffering from inflammatory bowel disease (IBD) in the Rhein-Main region, Germany, we detected serious discrepancies between treatment reality and treatment guidelines. Consecutively, the patient outcome in our cohort was compromised.

The aim of the study was to establish a network between primary deliverers of care for IBD patients and one large health care insurance company (BKK Taunus, second largest insurance company in Hesse, Germany) and to evaluate whether treatment of these IBD patients can be optimized.

Methods: 197 IBD patients insured by the BKK Taunus agreed to enter the disease management programme between 01.01.2009–30.09.2009. Patients gave informed consent that data about their disease entity and medical treatment were collected electronically, pseudonymised and analysed with regard to differences in therapy. Participating physicians were trained with respect to guideline conform treatment before the start of the programme. Three IBD experts judged independently about whether patients were treated according to actual treatment guidelines or not. Analysis of the medication costs was done by the BKK Taunus.

Results: There were significant changes in therapy management detectable, when patients entered the management programme: The proportion of patients treated according to guidelines was 50% before entering the programme and increased to 82%. Although medication costs rose, total costs could be diminished significantly, as secondary costs for in hospital treatment and days off work could be cut in half.

Conclusion: The study shows that networking of deliverers of care for IBD patients with health insurances provide an excellent possibility to optimize medical treatment and can cut down costs significantly.